Orphagen Pharmaceuticals - Crunchbase Company Profile & Funding

Q: How much funding has Orphagen Pharmaceuticals raised to date?

Orphagen Pharmaceuticals has raised obfuscated.

Overview

Orphagen Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Orphagen Pharmaceuticals

CB Rank

108335

Orphagen Pharmaceuticals is a drug discovery company.

Founded

obfuscation

Private

Grant

San Diego, California, United States

11-50

www.orphagen.com/

Biotechnology

Health Care

Medical

Funding Rounds

Grant

OBF

obfuscation

Key People

Scott Thacher: CEO and founder
Past Role: Io Therapeutics, Board of Directors, Co-founder

Details

Legal Name

Orphagen Pharmaceuticals, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Scott Thacher

About the Company

Orphagen Pharmaceuticals identifies and develops small compounds for therapeutic targets with tremendous untapped promise in areas of high clinical need.

Phone Number

+1 (858) 481-6191

Contact Email

info@orphagen.com

Predictions & Insights

Growth Insight

See this Growth Insight

Orphagen Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Awards

Products & Services

OR-449

A first-in-class small molecule antagonist targeting the orphan nuclear receptor steroidogenic factor-1 (SF-1) for treatment of adrenocortical cancer and certain squamous cancers.

OR-812

An oral small molecule antagonist of retinoic acid receptor alpha (RARα) developed for inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease.

Research & Development

Orphagen Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant
obfuscated obfuscation	Grant - Orphagen Pharmaceuticals	1	obfuscated obfuscation	National Institute of Diabetes and Digestive and Kidney Diseases	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institute of Diabetes and Digestive and Kidney Diseases	Yes	Grant - Orphagen Pharmaceuticals	—
National Institute of Diabetes and Digestive and Kidney Diseases	Yes	Grant - Orphagen Pharmaceuticals	—
National Institute of Diabetes and Digestive and Kidney Diseases	Yes	Grant - Orphagen Pharmaceuticals	—
National Institute of Diabetes and Digestive and Kidney Diseases	Yes	Grant - Orphagen Pharmaceuticals	—
National Institute of Diabetes and Digestive and Kidney Diseases	Yes	Grant - Orphagen Pharmaceuticals	—